Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000457073 | SCV000563466 | benign | DICER1-related tumor predisposition | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570246 | SCV000661825 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000570246 | SCV002533094 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-02 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478051 | SCV004221877 | benign | not provided | 2022-12-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960117 | SCV004773647 | likely benign | DICER1-related disorder | 2022-09-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |